SG Americas Securities
IRMD icon

SG Americas Securities’s iRadimed IRMD Stock Holding History

SG Americas Securities’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.08M Buy
73,561
+3,170
+5% +$317K 0.01% 910
2025
Q4 		$6.85M Buy
70,391
+33,072
+89% +$2.84M 0.01% 946
2025
Q3 		$2.66M Buy
37,319
+803
+2% +$53.5K 0.01% 804
2025
Q2 		$2.18M Buy
36,516
+29,339
+409% +$1.61M 0.01% 733
2025
Q1 		$377K Buy
7,177
+582
+9% +$32.7K ﹤0.01% 2012
2024
Q4 		$363K Buy
6,595
+3,664
+125% +$193K ﹤0.01% 1630
2024
Q3 		$147K Buy
+2,931
New +$135K ﹤0.01% 2754
2023
Q2 		– Sell
-2,975
Closed -$117K – 2713
2023
Q1 		$117K Buy
+2,975
New +$108K ﹤0.01% 2813

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SG Americas Securities's IRMD Position: Q1 2026 in Review

SG Americas Securities increased its iRadimed (IRMD) stake by 4.5% in Q1 2026, buying an estimated $317K and bringing the position to 73,561 shares worth $7.08M. The position accounts for 0.01% of the portfolio, ranked #910.

SG Americas Securities first reported a position in IRMD in Q1 2023 and has held it in 8 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • SG Americas Securities held 73,561 shares of iRadimed worth $7.08M as of Q1 2026.
  • SG Americas Securities bought 3,170 iRadimed shares in Q1 2026, an estimated $317K.
  • iRadimed made up 0.01% of SG Americas Securities's portfolio in Q1 2026, its #910 holding.
  • SG Americas Securities first reported a position in iRadimed in Q1 2023 and has held it in 8 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.